4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-26-023077
Chief Financial Officer sold 9,386 shares at $8.26 ($77,557)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NOUGUES MAXIMO F Chief Financial Officer | 2026-07-06 | Sale 10b5-1 | −9,386 | $8.26 | $77,557 | 230,637 | D |
| Open-market sales · 9,386 sh · avg $8.26 · $77,557 | |||||||
Loading xslF345X06/rdgdoc.xml…